Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.
Experts provide insights on tailoring treatment in patients with EGFR-mutant and wildtype NSCLC.
A multidisciplinary team discusses the role of immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC).
A multidisciplinary team of specialists discuss the use of targeted therapies for NSCLC with MET alterations.
Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.
Experts provide insights on tailoring treatment in patients with EGFR-mutant and wildtype NSCLC.
A multidisciplinary team discusses the role of immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC).
A multidisciplinary team of specialists discuss the use of targeted therapies for NSCLC with MET alterations.
Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.
Two oncologists and a pathologist discuss the implications of HER2 targeting in solid tumours, with a focus on NSCLC.
An oncologist and a pathologist discuss HER2 testing and treatments for HER2-altered NSCLC.
Prof. Wakelee discusses the latest evidence on immunotherapy for early-stage, resectable NSCLC.
Three experts discuss the pathogenesis, diagnosis and treatment for bronchiolitis obliterans syndrome (BOS).
A medical oncologist shares her insights on the current treatments for LS-SCLC and the remaining unmet needs
touchRESPIRATORY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events
An allergist shares her expert insights on the latest guidance for the diagnosis and management of food allergies, including the role of novel diagnostic tools and emerging therapies in clinical practice.
Dr Rebecca Heist discusses emerging antibody-drug conjugates for the second-line treatment of patients with advanced non-small cell lung cancer.
An allergist shares her expert insights and guidance on key clinical questions around the changing paradigm in the diagnosis and management of pet allergies.
Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.
Dr Balazs Halmos offers his perspective on immunotherapy for the treatment of squamous cell lung cancer.
Two lung cancer specialists discuss the current recommendations for biomarker testing and the latest data on MET inhibitors for the management of patients with MET alterations.
Leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.
Three experts discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
A leading expert discusses the current landscape and future perspectives of immune checkpoint inhibitors for the treatment of NSCLC
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.